One Year On, US FDA Generic Drug Cluster Focuses On Facilitating Collaboration

Group Has Made Significant Progress Regarding Data Sharing

 
• By Chloe Kent
Wooden figures of people gathered around green globe
Several initiatives in the off-patent industry are now focused on regulatory harmonization • Source: Shutterstock

More from Generics

More from Biosimilars & Generics